Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FX006 in Glenohumeral OA or Shoulder Adhesive Capsulitis (RANGE)
NCT04160091Phase 2Terminated
- Sponsor
- Pacira BioSciences
- Start
- Nov 2019
- Primary completion
- Jun 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of triamcinolone acetonide in glenohumeral osteoarthritis, adhesive capsulitis (AC), sponsored by Pacira BioSciences. Started Nov 2019; status: terminated.
02
Drugs
triamcinolone acetonide
03
Conditions
glenohumeral osteoarthritisadhesive capsulitis (AC)
Beyond the preview
Go deeper on NCT04160091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04160091.